Date  |
|
| Mar 26, 2020 |
ReShape Lifesciences Announces Fourth Quarter and Full Year 2019 Financial Results |
| Mar 23, 2020 |
ReShape Lifesciences to Host Fourth Quarter and Full Year 2019 Conference Call on March 26, 2020 |
| Nov 14, 2019 |
ReShape Lifesciences Announces Third Quarter 2019 Financial Results |
| Nov 11, 2019 |
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split |
| Nov 7, 2019 |
ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019 |
| Nov 5, 2019 |
ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R) |
| Oct 30, 2019 |
ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer |
| Oct 17, 2019 |
ReShape Lifesciences Announces Attendance and Presentation at Obesity Week 2019 |
| Sep 23, 2019 |
ReShape Lifesciences Enters into Early Warrant Exercise Transaction and Receives an Additional $7.65 Million in Proceeds |
| Sep 3, 2019 |
ReShape Lifesciences(TM) to Participate in the H. C. Wainwright Global Investment Conference |